Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages. - Driouich JS; Cochin M; Lingas G; Luciani L; Baronti C; Bernadin O; Gilles M; Villarroel PMS; Moureau G; Petit PR; Dupont A; Izopet J; et al. (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2024)